In vivo evidence of the specificity of effects of GABA(A) receptor modulating medications.
Krystal
Andrew D
AD
Insomnia and Sleep Research Program, Duke University School of Medicine, Duke University Medical Center Durham, NC 27710, USA. kryst001@mc.duke.edu
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D053961:Azabicyclo Compounds / Q000494:pharmacology; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D003975:Diazepam / Q000494:pharmacology; D004569:Electroencephalography / Q000187:drug effects; D000069582:Eszopiclone; D058785:GABA-A Receptor Agonists; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D051381:Rats; D011963:Receptors, GABA-A / Q000187:drug effects*; D000077334:Zolpidem
D053961:Azabicyclo Compounds; D058785:GABA-A Receptor Agonists; D006993:Hypnotics and Sedatives; D010879:Piperazines; D011725:Pyridines; D011963:Receptors, GABA-A; D000077334:Zolpidem; D000109:Acetylcholine; D003975:Diazepam; D000069582:Eszopiclone